Molecular Formula | C14H15NO4 |
Molar Mass | 261.27 |
Density | 1.317±0.06 g/cm3(Predicted) |
Melting Point | 222-224°C (dec.)(lit.) |
Boling Point | 464.7±45.0 °C(Predicted) |
Flash Point | 218.8°C |
Solubility | DMF: soluble |
Vapor Presure | 7.04E-08mmHg at 25°C |
Appearance | Solid |
Color | Bright orange solid; Orange crystals;Orange crystalline solid; Orange laths; Orangepowder; Orange so |
Maximum wavelength(λmax) | ['409 nm (Buffer pH 9.0)'] |
BRN | 6145963 |
pKa | -98.36 ± 0.20, most acidic, temperature:25 °C; 6.06 ± 0.20, most basic(at 25℃) |
Storage Condition | Keep in dark place,Inert atmosphere,Room temperature |
Refractive Index | 1.562 |
Hazard Symbols | Xi - Irritant |
Safety Description | S22 - Do not breathe dust. S24/25 - Avoid contact with skin and eyes. |
WGK Germany | 3 |
FLUKA BRAND F CODES | 8-10 |
HS Code | 29322090 |
Hazard Note | Irritant |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 3.827 ml | 19.137 ml | 38.275 ml |
5 mM | 0.765 ml | 3.827 ml | 7.655 ml |
10 mM | 0.383 ml | 1.914 ml | 3.827 ml |
5 mM | 0.077 ml | 0.383 ml | 0.765 ml |
biological application | Detecting hydrogenperoxide; evaluating irons; cysteine cathepsinsinhibitors; β-glucosidase inhibitors; humanmonoamine oxidase inhibitors; N-Methyl-D-aspartatereceptors (NMDARs) inhibitors; phosphateassay; probing actomyosin mechanism;treatingcancer/antitumor activity,treating cognitive deficits orschizophrenia;as a substrate for measuring proteinkinase activity |
main application | Epoxy resinsphotoluminescent devices;lithographic platematerials; Oil-repellent copolymers/coatings;polymer matrices; Silica nanoparticles for imaging,security, and sensing applications |
biological activity | 7ACC1(DEAC; Coumarin D 1421; D 1421) can selectively interfere with lactic acid flux in tumor microenvironment, inhibit lactic acid influx of tumor cells expressing MCT1 and MCT4, but has no effect on lactic acid outflow. |